Single‐centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides-Reference-Cited by-同舟云学术

Single‐centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides

Published:2021-12-07 Issue:2 Volume:186 Page:363-365
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Falkenhain‐López D.¹^ORCID,Fulgencio‐Barbarin J.¹^ORCID,Puerta‐Peña M.¹^ORCID,Montero‐Menárguez J.¹^ORCID,Sánchez‐Velázquez A.¹^ORCID,Ortiz‐Romero P.L.¹²

Affiliation:

1. Dermatology Department of the Hospital Universitario 12 de Octubre Madrid Spain

2. Institute i+12 Medical School University Complutense Madrid Spain

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20757

Reference8 articles.

1. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

4. Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic

5. Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides;Frontiers in Medicine;2024-01-18

2. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

3. Efficacy of single-agent chemotherapy with pegylated liposomal doxorubicin or gemcitabine in a diverse cohort of patients with recalcitrant cutaneous T-cell lymphoma;British Journal of Dermatology;2023-09-01

4. Doxorubicin-liposomal;Reactions Weekly;2022-08-06

5. Real‐life experience of using pegylated liposomal doxorubicin in primary cutaneous T‐cell lymphomas;Clinical and Experimental Dermatology;2022-07-08